This opportunity is now closed.

Funded PhD Opportunity

Autonomous Smart Patches: New Approaches to Controlled Drug Delivery

Subjects: Engineering and Biomedical Sciences


Summary

Background:

Transdermal drug patches have often been heralded as a pain free approach to the delivery of therapeutic agents and there has been considerable commercial interest with the availability of over the counter (nicotine) and prescription (fentanyl) products. Drug delivery is typically achieved through passive diffusion across the stratum corneum into the underlying microcirculation but the hydrophobicity of the skin barrier restricts the drug candidates to small molecular weight lipophilic species. Once applied, the dosage cannot be modulated other than simply removing the patch. Microneedles can offer a means of painlessly breaching the skin and allow the transport of polar/large molecular material (i.e. insulin).

While there have been extensive developments within this field, the majority remain limited by a lack of control over the release dynamics. The evolution of systems offering smarter, stimuli reactive, release has gathered pace with mechanical, electrical and light actuation systems coming to the fore.

Aim:

The proposed project will build on existing microneedle expertise within the group but incorporate the innovative element of electronic control over the timing, extent and frequency of reagent release. This would eventually set the foundations for an autonomous patch capable of administering personalised drug therapies.

Methodology:

The strategy exploits a composite microneedle structure comprising cellulose acetate phthalate (CAP) and a phase change material based on poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-PLGA). The outer CAP material provides structural integrity and piercing capability while the inner PEG-PLGA composite is key to the delivery control. The latter is solid at physiological temperatures but transitions to a liquid state at 40oC. Thus, integration of the microneedle composite with a small resistive heater which can be controlled via Bluetooth from a phone (Figure 1) could thereby enable more precise control over the release profile.

Proposed Plan:

Year 1. Production/characterisation of the composite microneedles and their thermal release properties using model drugs in simulated conditions. Optimisation of yield through investigating transfer from the MN baseplate through the needles.

Year 2. Establish appropriate models through which to evaluate MN delivery and transdermal yield through and within skin. Validation of device operation.

Year 3. Optimisation of patch constituents and technology demonstration through the controlled autonomous delivery (single/repetitive dosing) of micronutrients, analgesics and hormones. A key advantage of the proposed strategy is the ability to have a multi-needle patch enabling repetitive dosing over a prolonged period and which would eventually offer closed loop combination therapy dosing. Autonomous control through a smart phone app directly addresses issues of therapy compliance and would be particularly useful in contexts such as:  nutrition, chronic pain, cancer and dementia where regularity of dosing is critical for improving outcomes.

Upper Second Class Honours (2:1) Degree from a UK institution (overseas award deemed equivalent via UK NARIC) in Biochemistry, Biomolecular Sciences, Biomedical Engineering.


Essential criteria

  • Upper Second Class Honours (2:1) Degree or equivalent from a UK institution (or overseas award deemed to be equivalent via UK NARIC)
  • Experience using research methods or other approaches relevant to the subject domain


Funding

    DFE

    The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £ 14,777 per annum for three years. EU applicants will only be eligible for the fees component of the studentship (no maintenance award is provided).  For Non EU nationals the candidate must be "settled" in the UK.


Other information


The Doctoral College at Ulster University

Key dates

Submission deadline
Monday 18 February 2019

Interview Date
March 2019


Campus

Jordanstown campus

Jordanstown campus
The largest of Ulster's campuses


Contact supervisor

Professor James Davis


Other supervisors


Applying

Apply Online

Related Funded Opportunities in: Engineering , Biomedical Sciences

Diabetes

Subject:
Biomedical Sciences

 View Details

Engineering

Subject:
Engineering

 View Details

The regulation of rhamnolipid biosynthesis in Burkholderia thailandensis.

Closing date:
Tuesday 1 September 2020
Subject:
Biomedical Sciences

 View Details

Genomic Medicine

Subject:
Biomedical Sciences

 View Details

Stratified Medicine

Subject:
Biomedical Sciences

 View Details

Optometry and Vision Science

Subject:
Biomedical Sciences

 View Details

MRes in Biomedical Sciences

Subject:
Biomedical Sciences

 View Details

The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.

Closing date:
Tuesday 1 September 2020
Subject:
Biomedical Sciences

 View Details

Molecular Pathology of Glaucoma

Closing date:
Wednesday 1 January 2020
Subject:
Biomedical Sciences

 View Details

The design and analysis of a novel photo-activated antimicrobial system

Closing date:
Tuesday 1 September 2020
Subject:
Biomedical Sciences

 View Details